Welcome to Bristol Myers Squibb Washington

Bristol Myers Squibb’s robust presence in Washington state is transforming the way difficult-to-treat cancers are approached.

Our teams in Seattle and Bothell discover, develop, manufacture and commercialize therapies in Immuno-Oncology (I-O) and cell therapy. Through continued leadership in the rapidly developing fields of engineered cell-based therapies and biotherapeutics aimed at harnessing the power of immune cells to enhance or restore the body’s ability to fight cancer, we seek to advance novel treatments for cancer patients with precision and purpose. 

Meet our team

Learn about our leaders who are making a difference in Washington state.

Join us as we transform patient lives through science 

Everyday, each of us work to improve outcomes of patients fighting serious diseases. Together we’re building a better future for each other and the patients who need us the most. 

Driving innovation forward in Washington state

Learn about our broad scope of scientific innovation in Washington state.

Transforming cells into cancer fighters >

Building on our legacy of pioneering transformational science, Bristol Myers Squibb is the first company with two approved chimeric antigen receptor (CAR) T cell therapies in hematologic malignancies with two distinct targets addressing separate blood cancers. 

Confronting the complexities of cancer >

Bristol Myers Squibb is driven to understand human biology and the complexities of cancer in order to advance the next generation of cancer therapies.

Looking to the future of cell therapy >

Bristol Myers Squibb is pursuing a multitude of diverse approaches in cell therapy to attack disease from new perspectives. 

Blueprint for a breakthrough: Applying research learnings beyond the lab >

With multiple cell-based therapeutic approaches under investigation in blood cancers and beyond, Bristol Myers Squibb researchers like Justine Dell’Aringa are harnessing the immune system to reimagine the future of cancer treatment.

Cell therapy’s got talent – and is looking for more >

Major recruitment efforts are underway at Bristol Myers Squibb.

‘Serial killer’ CAR T cells target and destroy tumor cells in Bristol Myers Squibb lab >

BMS is a leader in autologous chimeric antigen receptor (CAR) T cell therapy, a type of cancer immunotherapy where a patient’s own T cells are genetically engineered to recognize and bind to proteins found on the surface of certain cancer cells. This video, shared by the Discovery Research team of the Immuno-Oncology and Cell Therapy (IO-CT) thematic research center (TRC) in Seattle, Washington, shows a tumor cell being destroyed by CAR T cells. 

Community impact

Learn how we are making a difference in communities across Washington state.

Empowering communities along the West Coast for a better tomorrow >

On the West Coast, Bristol Myers Squibb has a robust research, development and manufacturing presence, and we are investing in the local communities where our employees live and work by supporting programs, initiatives and organizations that help improve health, promote and expand STEM education and deliver basic human services through our community giving activities.

Give and take: The power of mentorship at Bristol Myers Squibb >

Learn about how the pass-it-on mentality of the company’s strong female leaders emboldens the next generation and helps advance the science.

Smile, you’re on camera, talking STEM >

Through a partnership with Seattle’s Pacific Science Center, nearly 30 Bristol Myers Squibb scientists shared their STEM expertise with the next generation.

People and business resource groups >

People and Business Resource Groups (PBRGs) represent one key strategy we use to support the business objectives, career advancement and development needs of our employees.

In pursuit of more female scientists: Breaking barriers for women in STEM >

Teri Foy, Ph.D., discusses her advocacy for women in STEM and frequently meets and presents to girls and women at schools in the Seattle area. 

Washington state regional fact sheet >

Learn more about our impact in Washington

Additional resources

Learn more about our scientific approaches and innovation.

Man on a mission >

Non-Hodgkin lymphoma survivor Nick Howe believes it was his mission to enroll in a cell therapy clinical trial to discover new treatment options for patients like him.

Cell therapy resources >

Discover how cell therapies are unlocking new potential in cancer research.

Understanding cell therapy >

Learn more about cell therapy and our approach to cell therapy research.

Cell therapy manufacturing infographic >

Bristol Myers Squibb is advancing cell therapy research through novel manufacturing approaches and a well-established supply chain platform across a broad network of state-of-the-art facilities with cutting-edge technologies and highlight trained manufacturing teams.

Understanding the CAR T cell therapy treatment experience >

Learn more about the patient journey on CAR T.

Targeting cancer with CAR T cell therapy >

Read about the science of CAR T cell therapy and cutting-edge research.

Explore our comprehensive approach to cancer research >

Learn how our comprehensive pipeline, spanning multiple approaches across platforms and modalities, sets us apart and enables us to fulfill our vision of transforming patients’ lives through science.